| ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis JR Cubillos-Ruiz, PC Silberman, MR Rutkowski, S Chopra, ... Cell 161 (7), 1527-1538, 2015 | 761 | 2015 |
| Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation MR Rutkowski, TL Stephen, N Svoronos, MJ Allegrezza, AJ Tesone, ... Cancer cell 27 (1), 27-40, 2015 | 304 | 2015 |
| Tumor cell–independent estrogen signaling drives disease progression through mobilization of myeloid-derived suppressor cells N Svoronos, A Perales-Puchalt, MJ Allegrezza, MR Rutkowski, KK Payne, ... Cancer discovery 7 (1), 72-85, 2017 | 180 | 2017 |
| SATB1 expression governs epigenetic repression of PD-1 in tumor-reactive T cells TL Stephen, KK Payne, RA Chaurio, MJ Allegrezza, H Zhu, J Perez-Sanz, ... Immunity 46 (1), 51-64, 2017 | 142 | 2017 |
| Transforming growth factor β-mediated suppression of antitumor T cells requires FoxP1 transcription factor expression TL Stephen, MR Rutkowski, MJ Allegrezza, A Perales-Puchalt, AJ Tesone, ... Immunity 41 (3), 427-439, 2014 | 126 | 2014 |
| Alteration of the tumor stroma using a consensus DNA vaccine targeting fibroblast activation protein (FAP) synergizes with antitumor vaccine therapy in mice EK Duperret, A Trautz, D Ammons, A Perales-Puchalt, MC Wise, J Yan, ... Clinical Cancer Research 24 (5), 1190-1201, 2018 | 113 | 2018 |
| Low birth weight: is it related to assisted reproductive technology or underlying infertility? LA Kondapalli, A Perales-Puchalt Fertility and sterility 99 (2), 303-310, 2013 | 113 | 2013 |
| Engineered transfer RNAs for suppression of premature termination codons JD Lueck, JS Yoon, A Perales-Puchalt, AL Mackey, DT Infield, MA Behlke, ... Nature communications 10 (1), 822, 2019 | 103 | 2019 |
| Satb1 overexpression drives tumor-promoting activities in cancer-associated dendritic cells AJ Tesone, MR Rutkowski, E Brencicova, N Svoronos, A Perales-Puchalt, ... Cell reports 14 (7), 1774-1786, 2016 | 102 | 2016 |
| Follicle-stimulating hormone receptor is expressed by most ovarian cancer subtypes and is a safe and effective immunotherapeutic target A Perales-Puchalt, N Svoronos, MR Rutkowski, MJ Allegrezza, AJ Tesone, ... Clinical Cancer Research 23 (2), 441-453, 2017 | 96 | 2017 |
| BTN3A1 governs antitumor responses by coordinating αβ and γδ T cells KK Payne, JA Mine, S Biswas, RA Chaurio, A Perales-Puchalt, ... Science 369 (6506), 942-949, 2020 | 94 | 2020 |
| A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8+ T-cell Responses, Impacting Tumor Challenge EK Duperret, A Perales-Puchalt, R Stoltz, H GH, N Mandloi, J Barlow, ... Cancer immunology research 7 (2), 174-182, 2019 | 92 | 2019 |
| Frontline Science: Microbiota reconstitution restores intestinal integrity after cisplatin therapy A Perales-Puchalt, J Perez-Sanz, KK Payne, N Svoronos, MJ Allegrezza, ... Journal of leukocyte biology 103 (5), 799-805, 2018 | 80 | 2018 |
| Pregnancy outcomes after kidney transplantation-immunosuppressive therapy comparison A Perales-Puchalt, JM Vila Vives, J López Montes, VJ Diago Almela, ... The Journal of Maternal-Fetal & Neonatal Medicine 25 (8), 1363-1366, 2012 | 77 | 2012 |
| Effect of delayed umbilical cord clamping on blood gas analysis J Valero, D Desantes, A Perales-Puchalt, J Rubio, VJD Almela, A Perales European Journal of Obstetrics & Gynecology and Reproductive Biology 162 (1 …, 2012 | 72 | 2012 |
| Ovulation induction in women with polycystic ovary syndrome A Perales-Puchalt, RS Legro Steroids 78 (8), 767-772, 2013 | 69 | 2013 |
| The tumor macroenvironment: cancer-promoting networks beyond tumor beds MR Rutkowski, N Svoronos, A Perales-Puchalt, JR Conejo-Garcia Advances in cancer research 128, 235-262, 2015 | 64 | 2015 |
| Risk factors for vertical transmission of hepatitis C virus: a single center experience with 710 HCV-infected mothers A Garcia-Tejedor, V Maiques-Montesinos, VJ Diago-Almela, ... European Journal of Obstetrics & Gynecology and Reproductive Biology 194 …, 2015 | 59 | 2015 |
| Mesothelin expression is associated with poor outcomes in breast cancer YR Li, RR Xian, A Ziober, J Conejo-Garcia, A Perales-Puchalt, CH June, ... Breast cancer research and treatment 147, 675-684, 2014 | 53 | 2014 |
| Trametinib drives T-cell–dependent control of KRAS-mutated tumors by inhibiting pathological myelopoiesis MJ Allegrezza, MR Rutkowski, TL Stephen, N Svoronos, ... Cancer research 76 (21), 6253-6265, 2016 | 51 | 2016 |
Julia TchouDepartment of Surgery, University of PennsylvaniaVerified email at uphs.upenn.edu
